November 2014—Combination of blood tests for fibrosis and cirrhosis to assess liver prognosis in CHC: Newer therapies for chronic hepatitis C are promising due to a high rate of sustained viral response and few side effects. Although these therapies are not yet readily available, investigators are considering the best way to evaluate and monitor response.
The post Clinical Pathology Selected Abstracts, 11/14 appeared first on CAP TODAY.
